As of January 1, 2018, the FMCSA changed some of the drugs it requires testing for. It is still considered a 5 panel test as follows:
Under ‘Opioids’, previously ‘Opiates’, DOT testing will continue to include confirmatory testing, when appropriate, for Codeine, Morphine, and 6-AM (heroin). But now they added initial and confirmatory testing for the semi-synthetic opioids Hydrocodone, Hydromorphone, Oxycodone, and Oxymorphone to this Opioids group. Some brand names for the semi-synthetic opioids include OxyContin®, Percodan®, Percocet®, Vicodin®, Lortab®, Norco®, Dilaudid®, Exalgo®.
Under Amphetamines, DOT testing includes confirmatory testing, when appropriate, for Amphetamine, Methamphetamine, MDMA (ecstasy) and MDA (ecstasy metabolite) To this Amphetamines group, they added initial testing for MDA and removed testing for MDEA.
Since January 1st, the FMCSA has required confirmation testing for 14 drugs under a 5‑panel test. Broken out, here is what DOT drug testing looks like:
If you need a DOT or non DOT drug test give our office a call today at If you have specific questions regarding the testing procedure please ask for Dr. Kevin E. Crowley. We are located in Alexandria, Ky. in Campbell county.